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The goals of point-of-care testing (POCT) are to facilitate rapid evidence-based
decisions, to improve patient outcomes, and, ultimately, to be robust and reliable
enough for on-site applications in emergency and disaster settings worldwide.
The objectives of this article are (1) to review current POC technologies used in
disaster and emergency care, (2) to understand first responder needs, (3) to outline
device design criteria based on gap analysis, and (4) to present strategies for
improving future POCT for efficiency, effectiveness, and targeted treatment during
on-site field operations.
This article is evidence-based in that it presents preliminary results of a needs
assessment survey in the United States. Readers are encouraged to participate in
the needs assessment survey. Please see the instructions provided in Table 1.This study was supported by the Point-of-Care Testing Center for Teaching and Research
(POCTCTRSM), School of Medicine, University of California, Davis, and by a NIBIB Point-of-Care
Technologies Center grant (Dr Kost, PI, NIH U54 EB007959). The content is solely the responsi-
bility of the authors and does not necessarily represent the official views of the National Insti-
tute of Biomedical Imaging and Bioengineering or the National Institutes of Health.
Department of Pathology and Laboratory Medicine, UC Davis-LLNL Point-of-Care Technologies
Center [NIBIB, NIH], Point-of-Care Testing Center for Teaching and Research (POCTCTR),
School of Medicine, University of California, 3455 Tupper Hall, Davis, CA 95616, USA
* Corresponding author.
E-mail address: gjkost@ucdavis.edu (G.J. Kost).
Clin Lab Med 29 (2009) 583–605
doi:10.1016/j.cll.2009.07.014 labmed.theclinics.com
0272-2712/09/$ – see front matter ª 2009 Elsevier Inc. All rights reserved.
Table 1
SurveyMonkey Instructions
Step Instruction and Access
One Visit UC Davis-LLNL POCT.
Web site: http://www.ucdmc.ucdavis.edu/pathology/poctcenter
Two The Clinical Needs Assessment survey link appears in the top right corner of the
navigation bar. It is the first item under POC Technologies Center. Please click on
‘‘Needs Assessment Survey’’
Three Please contact Keith Brock, Research Specialist, at 530 752 8471, email: tkbrock@
ucdavis.edu, to receive an accession number
Four Follow the instructions on the screen to complete the survey. Note: Your progress will
be saved after pressing the ‘‘next’’ button at the end of each page. Please note, your
progress online is managed through your web browser cookies. Please complete the
survey on the same computer and do not delete the cookies on your web browser
before completion of the online survey
Five Thank you for your time and input on the survey!
Kost et al584The 2004 tsunami in Southeast Asia and Hurricane Katrina in the United States
exposed the lack of disaster preparedness worldwide.1 Although the feasibility of
POCT was proven, and the disaster responses were extensive, follow-up studies
showed rescue was slow and inadequate.1 In Hurricane Katrina, flooded hospitals,
roads, and communications hindered rescue efforts by first responders who carried
limited POCT devices such as oxygen saturation monitors (pulse oximeters), blood
glucose meters, and other small handhelds.1 Furthermore, POCT instruments failed
to operate effectively under adverse environmental conditions at respective disaster
locations, where temperatures reached 110F (43C) or higher in hospitals.2,3
Broadly regional catastrophes, such as these recent ‘‘newdemics,’’4,5 lead to
sequentially magnified setbacks. Others, such as the current novel H1N1 pandemic,
threaten entire nations. Typically, communities lack the POCT resources necessary
to effectively handle the disaster situations they face.1 Conversely, newdemics high-
light the significant potential for POCT to positively impact preparedness, disaster
response, and patient outcomes. Current experiences, including the surprise appear-
ance of the novel H1N1 pandemic in Mexico (unpublished observation), emphasize
the need for new sturdy, handheld, and robust POC technologies capable of effec-
tively operating in a variety of field locations.
In the future, better prepared first responders will carry reliable POCT diagnostics
wherever disaster and emergency situations arise. Thus, POC user needs are being
established through objective evidence-based national surveys (see Table 1) as a first
step in identifying suitable device designs, effective test clusters, and environmental
operating conditions.6 The preliminary survey results are reported.NEEDS ASSESSMENT SURVEY: PRELIMINARY RESULTS
Participants
Forty disaster care experts were randomly selected from the editorial boards of the
American Journal of Disaster Medicine (AJDM) and Disaster Medicine Public Health
and Preparedness (DMPHP) using a random number generator (Minitab, State
College, PA). This sample included physicians, public health officials, researchers,
pathologists, first responders, and military personnel.
Point-of-Care Testing for Disasters 585Development
A survey was developed based on literature review and multidisciplinary consultations
that included professors of bioengineering, emergency medicine, infectious diseases,
and critical care medicine. ‘‘Visual logistics,’’ defined as graphics and pictorial media
for common sense portrayal of questions, concepts, and designs, are introduced to
build survey questions with the objective of generating easy to comprehend concepts
without laborious text or lengthy explanation. Set theory (eg, Venn diagrams) was used
whenever possible to compare 2 or more visual concepts, questions, and the results.
To encourage participation and simplify distribution and return, a visual logistics
web-based survey was developed (SurveyMonkey, Portland, Oregon). Paper-based
and web-based surveys used identical graphics and questions. The survey was
divided into 4 parts: (1) demographic questions, (2) device design questions in 10
sections, (3) pathogen test cluster design questions in 4 sections, and (4) trade-off
blocks that led to heuristic ranking of POC design features. At the time of this prelim-
inary report, parts 1 to 3 were implemented.
Procedures
If possible, personal contact was initiated by phone followed by shipment of a FedEx
package containing an invitation letter, the paper-based survey, and a prepaid return
envelope. The invitation letter explained the goal of the survey, provided instructions
for participation, and included a hyperlink to the web-based survey (see Table 1).
Email also was used to distribute the survey request and hyperlink. This preliminary
report reflects survey results obtained between March 1 and June 14, 2009. The
survey was conducted in compliance with the UC Davis Institutional Review Board.
Statistics
Data obtained from the survey were analyzed using nonparametric Pearson chi-square
exact tests (SAS,Gary,NorthCarolina). Statistical significancewasdefinedas: *,P<.05;
**, P<.01; and ***, P<.001.
Pathogen test cluster rank results were analyzed by assigning each pathogen
a weighted score. The score for each rank was calculated using the following equa-
tion: Si5 ð11 RiÞ. Ri is defined as the rank of each pathogen assigned by a survey
participant, such that i5 ½1; n, where n is the number of ranks. When the respondent
designated the same rank for 2 or more organisms, the average rank was calculated
and assigned to each organism.
The weighted score was calculated by summing the product of each score and cor-
responding frequency using the following equation: WSj5
P
i51
Si  Fij. The frequency,
Fij is defined as the number of times survey participants ranked a pathogen a specific
value, such that j5 ½1;N, where N is the number of pathogens.
PRELIMINARY RESULTS
Demography
Of the 40 disaster medicine experts surveyed, 25 responses were received, giving
a response rate of 62%. The respondents included 8 physicians (32%), 9 public health
officials/hospital managers (36%), 3 pathologists (12%), and 5 emergency room
doctors (20%).
Device Design
Fig. 1 illustrates visual logistics, specifically pictorial media that introduced the survey
question on what the respondent preferred with regard to instrument formats for
Fig. 1. Device design format. Visual logistics were used to illustrate 3 device format selections
for POCT instruments. (A) Transportable device on a cart. (B) Portable, bench-top device with
a handle for carrying. (C) Small battery-operated handheld device.
Kost et al586given clinical settings. The results showed that in disaster settings, respondents
showed a significant preference for handheld diagnostics (Fig. 2) and cited increased
portability and versatility as the rationale.
When respondents were asked to choose between a device that tests multiple
patient samples in parallel for a single pathogen versus a device that performs multi-
plex testing of several pathogens for a single patient sample (Fig. 3), respondents
preferred a multiplex test in the urgent care and emergency room settings (Fig. 4).
Participants cited the need to quickly screen a large volume of patients in a disaster
setting, whereas a full workup is necessary in urgent care and emergency room
settings. Several of the respondents who chose the device that parallel processesFig. 2. Selection of format by survey respondents. In disaster settings, participants preferred
handheld devices (***P<.001). For urgent care and emergency-room settings, there were no
statistically significant differences in preferences.
Fig. 3. Multiple patients versus multiplex pathogens. Visual logistics were used to illustrate 2
testing methods for POCT devices. (A) Testing multiple patients for 1 pathogen. (B) Multi-
plex pathogen testing, in which 1 patient sample is simultaneously tested for the presence
of multiple pathogens (underline).
Point-of-Care Testing for Disasters 587multiple patient samples for a single pathogen given a disaster setting, referenced
biothreat or pandemic scenarios.
Fig. 5 shows 2 different sample collection methods, a test cassette and vacutainer.
A test cassette provides a housing platform in which one can automate preanalytical
processing steps that are critical to subsequent analytical steps that follow on the
POC device. Fig. 6 reflects general acceptance of test cassettes in disaster, urgent
care, and emergency settings.
Respondents were also asked to state their preference between 2 potential waste
disposal methods (Fig. 7). The first scheme suggests an instrument that stores
biohazard waste in a reusable waste storage reservoir to be emptied periodically. A
test cassette, used to transport the sample to the instrument, would also need to
be properly discarded after a single use. The second scheme shows an instrument
that stores all biohazard waste in the disposable test cassette, which then is discarded
after a single use. Fig. 8 shows a statistically significant preference of respondents for
the disposable test cassette in the second scheme across all 3 clinical settings, with
a higher level of statistical significance (P<.01) of the preference in disaster and emer-
gency room settings.
Fig. 4. Selection of testing method by survey respondents. In disaster settings, both
approaches to pathogen detection may be useful. However, respondents preferred multi-
plex testing to testing multiple patients for 1 pathogen in urgent care (***P<.001) and
emergency room (**P<.01) settings.
Kost et al588Pathogen Test Cluster Design
Table 2 shows the weighted scores of the top 10 pathogens for each of 4 scenario
sections. For a general disaster test cluster, Vibrio cholerae had the highest weighted
score (117); whereas for a blood donor screening test cluster, HIV 1 and 2 had the
highest weighted score (224). Depending on the clinical scenario, the specificFig. 5. Test cassettes versus vacutainers. Visual logistics were used to illustrate 2 sample
collection methods for POCT instruments. (A) A vacutainer is used to collect the blood
sample, allowing for multiple blood collection tubes to be drawn at one time. (B) Test
cassette blood sample collection; blood is drawn directly into a disposable test cassette,
processed, and a result given. Graphics updated for the survey currently in use.
Fig. 6. Selection of sample collection method by survey respondents. Test cassettes and vacu-
tainers were equivalent in all but the disaster setting, but this result was not statistically
significant in this preliminary survey report.
Fig. 7. Biohazard disposal methods. Visual logistics were used to illustrate 2 biohazard
disposal methods for POCT devices. (A) Biohazard waste in a reusable waste storage reser-
voir that must be emptied periodically, and a disposable test cassette for single use. (B) A
device that stores all biohazard waste in a disposable test cassette that is discarded after
a single use. Graphics updated for the survey currently in use.
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Fig. 8. Uniform selection of waste disposal by disposable test cassette by survey respondents.
There is a statistically significant preference for disposable test cassettes across all 3 clinical
settings (P<.01, 0.05, and 0.01). See Fig. 6. Disposable test cassettes have merit for sample
collection and waste disposal in disaster settings. *P<.05; **P<.01.
Kost et al590pathogens a POC device would detect varies. For instance, methicillin-resistant
Staphylococcus aureus (MRSA) had the highest weighted score at 147 for the blood-
stream pathogen test cluster (see Table 2). However, in the pandemic test cluster,
influenza A/B had the highest weighted score at 189, whereas MRSA was fifth with
a weighted score of 112.5 (see Table 2).PRELIMINARY RESULTS VERSUS CURRENT DISASTER PATHOGENS
Various POCT devices that test for a variety of analytes and pathogens are used during
disaster and emergency situations, such as Hurricane Katrina. Emergency medical
responders, disaster medical assistance teams (DMATs), international medical-
surgical response teams (IMSuRTs), and other first responders deploy to disaster sites
carrying POCT devices.6 They use POCT devices to test, rapidly diagnose, and, as
indicated, treat victims.6 Depending on where responders are deployed, the patho-
gens they encounter will vary, possibly unpredictably and unexpectedly. Table 37–32
documents the variety of pathogens present in several modern disasters, such as
flooding, hurricanes, and earthquakes. When comparing the top 10 pathogens identi-
fied by preliminary needs assessment survey results in various disaster scenarios (see
Table 2) with pathogens found in major disasters, there was substantial overlap.
During Hurricane Katrina, for example, various pathogens were identified that also
were selected and ranked by experts and surveyed as high priority for general
disaster, blood donor screening, bloodstream pathogen, and pandemic test clusters.
Specifically, in Table 2 for the general disaster scenario and in Table 3 for Hurricane
Katrina, there is overlap for Vibrio cholerae, MRSA, and Escherichia coli. Thus, prelim-
inary survey results demonstrate that survey experts identified pathogens encoun-
tered at disaster sites (see Table 3) as important for having POCT devices capable
of detecting these organisms (see Table 2).
Table 2
Pathogen test clusters
Weighted Score Pathogen
A. General disaster
test cluster (n 5 18)
117 Vibrio cholerae
108 Escherichia coli
100 Staphylococcus aureus
77 Yellow fever
73 Salmonella enterica
66 Pseudomonas aeruginosa
62 Plasmodium falciparum
54 Enterobacter species
49 Dengue fever virus
38 Klebsiella species
B. Blood donor screening
test cluster (n 5 23)
224 HIV 1 and 2
190 Hepatitis B
190 Hepatitis C
125.5 Human T cell lymphotropic virus 1 and
2 (HTLV 1 and 2)
109.5 West Nile virus
109 Cytomegalovirus
93 Dengue fever
77 Parvovirus B19
74 Epstein-Barr virus
46 Chikungunya
C. Bloodstream pathogen
test cluster (n 5 20)
147 Methicillin-resistant
Staphylococcus aureus
118 Escherichia coli
91 Pseudomonas aeruginosa
90.5 Streptococcus pneumoniae
90 Enterobacter species
87.5 Methicillin-sensitive
Staphylococcus aureus
79 Klebsiella species
61 Enterococcus faecalis
50 Streptococcus pyogenes
48 Coagulase-negative Staphylococcus
D. Pandemic test
cluster (n 5 22)
189 Influenza A/B
121.5 Parainfluenza 1, 2, 3
115.5 Streptococcus pneumoniae
112.5 Respiratory syncytial virus
112.5 Methicillin-resistant
Staphylococcus aureus
100 Haemophilus influenza
90.5 Mycobacterium tuberculosis
87 Adenovirus
57 Mycoplasm pneumoniae
51.5 Metapneumovirus
Point-of-Care Testing for Disasters 591A similar finding was observed when comparing pathogens detected at the tsunami
disaster site in Southeast Asia (see Table 3) versus the general disaster and blood-
stream pathogen test clusters ranked highly in Table 2. Survey results identified
several pathogens in the general disaster and bloodstream pathogen test clusters,
such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, MRSA,
and Salmonella species. These pathogens also were detected at tsunami disaster
Kost et al592sites in Southeast Asia. Having POCT devices capable of testing for these pathogens
found at particular disaster sites can facilitate rapid diagnosis. Targeted therapy, in
turn, can conserve drugs (eg, antimicrobials) that become depleted quickly during
the initial crisis stages. These survey results should be used as a guide for develop-
ment of new POCT devices capable of timely pathogen detection at disaster sites.CURRENT USE OF POCT IN DISASTERS IN THE UNITED STATES
New POC devices must be capable of testing for a variety of pathogens present at
a particular disaster site, and also properly integrated and used to decrease responseTable 3
Pathogens in disasters
Scenario Location, Year Pathogens Detected (Isolation Site) Path of Infection
Drought Florida, 5 epidemics
since 19527,8
Saint Louis encephalitis (blood) Vector borne
West Nile (blood) Vector borne
Indonesia, 19979 Malaria (blood) Vector borne
Earthquake California, 199410 Coccidioides immitis (skin) Dust cloud
China, 200811 Staphylococcus aureus (pus and
wound)
Wound
Escherichia coli (pus and wound) Wound
Acinetobacter
baumannii (pus and wound)
Wound
Enterobacter cloacae (pus
and wound)
Wound
Pseudomonas aeruginosa
(pus and wound)
Wound
Turkey, 199912 Pseudomonas aeruginosa (wound) Wound
Acinetobacter baumannii (wound) Wound
Methicillin-resistant
Staphylococcus aureus (wound) Wound
Candida species (wound) Wound
Turkey, 199913 Acinetobacter species (wound) Wound
Pseudomonas aeruginosa (wound,
blood, urine)
Wound
Methicillin-resistant
Staphylococcus aureus (wound,
blood, urine)
Wound
Serratia marcescens (wound) Wound
Klebsiella pneumoniae (wound) Wound
Enterobacter species (wound) Wound
Candida albicans (wound) Wound
Flooding Bangladesh, 200414 Escherichia coli (blood) Water, food
borne
Vibrio cholerae (stool)
Global, 1980–200815 Malaria (blood) Vector borne
Yellow fever (blood) Vector borne
West Nile (blood) Vector borne
Dengue (blood) Vector borne
Indonesia, 200416 Salmonella paratyphi (blood) Water, food
borne
Nonspecific17,18 Streptococcus pneumoniae
(blood)
Inhalation
(continued on next page)
Table 3
(continued)
Scenario Location, Year Pathogens Detected (Isolation Site) Path of Infection
Hurricanes/
tornadoes
Katrina, 200519–23 Nontoxigenic Vibrio cholerae O1
(blood)
Food borne
Vibrio cholerae non-O1 (blood) Water borne
Vibrio vulnificus (blood) Wound, food borne
Vibrio parahaemolyticus (blood) Wound, food borne
Methicillin-resistant Wound
Staphylococcus aureus (wound)
Norovirus (stool) Water borne
Vibrio species (lake surface water) Water borne
Legionella species (lake surface
water)
Water borne
Cryptosporidium (interior canal
water)
Water borne
Giardia (interior canal water) Water borne
Escherichia coli
(shoreline canal water)
Water borne
Bifidobacterium (shoreline canal
water)
Water borne
Georgia, 200024 Serratia marcescens (wound) Wound
Pseudomonas aeruginosa (wound) Wound
Enterococcus (wound) Wound
Low-
resource
settings/
rural
areas
Indonesia,
2001–200316
Salmonella enterica (blood) Food, water borne
Salmonella paratyphi (blood) Food, water borne
Salmonella typhi (blood) Food, water borne
Philippines,
1994–199625
Streptococcus pneumoniae
(blood)
Inhalation
Haemophilus influenzae (blood) Inhalation
Tsunamis Thailand, 200426–29 Aeromonas (pus and wound) Wound
Escherichia coli (stool) Water, food borne
Klebsiella pneumoniae (pus and
wound)
Wound
Pseudomonas aeruginosa (pus and
wound)
Wound
Burkolderia pseudomallei (blood) Soil, water borne
Acinetobacter baumannii (blood) Soil, water borne
Stenotrophomonas (blood) Soil, water borne
Methicillin-resistant
Staphylococcus aureus (wound) Wound
Staphylococcus aureus (wound) Wound
Candida species (blood) Inhalation, wound
Aspergillus species (blood) Inhalation, wound
Scedosporium species (blood) Inhalation, wound
Salmonella species (well water) Water borne
Clostridium species (wound) Soil
Aeromonas species (wound) Water borne
World Trade
Center
disaster
New York,
200130–32
Asthma and WTC cough
(pathogens not named)
Point-of-Care Testing for Disasters 593
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Point-of-Care Testing for Disasters 595times and improve patient outcomes. During Hurricane Katrina, a variety of different
locations and types of POCT were used featuring an array of POC tests covering
chemistry, hematology, and other analyte categories.
Fig. 9 highlights POC instruments, including the various locations and POCT oper-
ators in Hurricane Katrina. Hospitals, evacuation sites, and local agencies were not
prepared for the disaster and offered few POCT devices and tests. Hurricane Katrina
is an example of a newdemic.5 Supplies depleted quickly. Needs for chronic moni-
toring, such as outpatient glucose monitoring, were not met.
Fig. 10 displays Hurricane Katrina disaster sites, arrival, and responses of mostly
military assets, and a suggested optimal POCT plan (upper right in figure) for timely
disaster response. Fig. 10 also documents that the disaster response time was
slow. Current POCT disaster preparation does not meet adequate standards and
must be improved for future preparedness. Proper strategic placement of POCT,
possibly in alternate medical care facilities, is needed to facilitate rapid diagnosis
and treatment.33
Pandemic influenza strains, such as novel H1N1, have the potential to significantly
increase mortality and morbidity, as well as quickly deplete resources of current health
care infrastructures. Thus, for example, rapidly diagnosing a particular influenza strain
using POCT devices is advantageous. Furthermore, the World Health Organization
(WHO) strongly recommends the use of POCT devices for quick influenza
diagnosis. Commercially available POC tests for influenza A and B are listed in
Table 4.34–38 Several of the tests currently available are immunoassays that target
nucleoprotein or matrix protein to identify influenza A or B types, but rarely offer further
subtyping.
However, nucleic acid recognition (NAR) for detection of influenza A or B has shown
promising benefits (see Table 4). These NAR devices exhibit greater sensitivity and
can provide subtyping data. Once a subtype of influenza is positively identified, health
care personnel and public health workers have the ability to start surveillance of new
strains in a particular area. In addition, subtyping of influenza has the ability to guide
antiviral treatment by identifying particular influenza strains that may be resistant or
sensitive to antiviral treatment.Fig. 9. Locations and types of POCT in Hurricane Katrina. Hospitals, evacuation sites, and local
agencies were not prepared fully to assist quickly with POCT. They carried few POCT instru-
ments. In contrast, US military ships and combat support units were equipped with POCT
devices, including a variety of tests to facilitate rapid diagnosis and treatment. Donations
of glucose meters proved valuable, but not fast enough or adequate for the large numbers
of diabetic victims involved in the disaster. POC tests used during the disaster include: ALP,
alkaline phosphatase; ALT, alanine aminotransferase; aPTT, activated partial thromboplastin
time; AST, aspartate aminotransferase; BNP, B-type natriuretic peptide; BUN, blood (serum)
urea nitrogen; CK, creatine kinase; cTn, cardiac troponin; GGT, g-glutamyltransferase; Hb,
hemoglobin; Hct, hematocrit; HDL, high-density lipoprotein; INR, international normalized
ratio; LD, lactate dehydrogenase; MB, MB fraction of CK; PT, prothrombin time; SO2, oxygen
saturationmeasured by pulse oximetry; TCO2, total carbon dioxide content; TP, total protein.
Instrument identifications: Bayer Acsensia, http://www.bayercarediabetes.com; Cardiac
STATus, http://www.spectraldx.com; Cell-Dyn, http://www.abbottdiagnostics.com; i-STAT,
http://www.i-stat.com; Ortho Diagnostics blood typing, http://www.orthoclinical.com;
Piccolo, http://www.abaxis.com; Rapidpoint coag, http://www.bayer-poct.co.uk; and Triage,
http://www.biosite.com. (From Kost GJ, Tran NK, Tuntideelert M, et al. Hurricane Katrina,
the tsunami and point-of-care testing: optimizing rapid response diagnosis in disasters. Am
J Clin Pathol 2006;126:513–20. ª 2006 American Society for Clinical Pathology; Courtesy of
Knowledge Optimization, Davis, CA; with permission.)
:
Fig.10. Hurricane Katrina disaster areas, arrival times of military and civilian assets, sequential responses, and optimal POCT plan for disaster response.
Mobile and military resources, including POCT, arrived on days 1, 3 to 5, 9, and 24. At the community and regional hospitals surveyed, beds averaged 154
(SD, 66; median, 173; range, 60–211) and 397 (SD, 249; median, 326; range, 174–763), respectively. Physicians ranged from 50 to 900. Displacement of 5944
physicians from the disaster area (223,000 km2) hampered an already devastated health care infrastructure. The authors recommend (upper right) opti-
mizing disaster response by prepositioning POCT for emergency use during the first 2 critical days. ICU, intensive care unit; OR, operating room. (From
Kost GJ, Tran NK, Tuntideelert M, et al. Hurricane Katrina, the tsunami and point-of-care testing: optimizing rapid response diagnosis in disasters. Am J
Clin Pathol 2006;126:513–20. ª 2006 American Society for Clinical Pathology; Courtesy of Knowledge Optimization, Davis, CA; with permission.)
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Point-of-Care Testing for Disasters 597For instance, several H1N1 strains of influenza were resistant to oseltamivir in fall
2008; however, in spring 2009, the novel H1N1 influenza strain (‘‘swine flu’’) was sensi-
tive to oseltamivir. Furthermore, in a recent study conducted by Dr Nishiura and
colleagues,39 the use of quarantine and rapid diagnostic testing to prevent or delay
the spread of pandemic influenza across island nations was evaluated. In order for
quarantine strategy to be effective in preventing or delaying the spread of pandemic
influenza, rapid and reliable diagnostic testing must be used to positively identify index
cases (first victims) with influenza.39 Thus, the use of POCT to rapidly diagnose and
subtype influenza has significant potential to refine pandemic disaster response and
prevent newdemics from spreading outside the bounds of initial disaster or emer-
gency locations.
This concept is important for disasters on the horizon, such as extensively drug-
resistant malaria and tuberculosis. Globally, tuberculosis represents a major problem,
especially in low-resource settings, such as impoverished African nations. Current
tests available often fail to correctly identify tuberculosis, are not rapid, and cannot
identify drug resistance.40 Rapid-liquid culture shows promising results for tubercu-
losis detection by improving the sensitivity, speed, reliability, and multidrug-resistant
tuberculosis detection.40 Future thinking is required for developing POCT devices that
are proven to simultaneously be rapid, simple, reliable, and cost-effective for
diagnosing extensively drug-resistant tuberculosis.40PREPAREDNESS: GAPANALYSIS
POCT devices typically encounter harsh environmental conditions, temperature
extremes, and high humidity in emergency and disaster care. Despite substantial
improvements, gaps still exist between current POCT technologies and real-world
needs. Inability of POCT instruments and reagents to withstand harsh conditions
present at disaster and emergency sites compromises performance.6 For example,
glucose test strips and blood gas cartridges may not provide accurate measurements
at disaster sites because thermal stresses adversely and inconsistently affect perfor-
mance.6 Because of these types of limitations and the obvious technical gaps in POC
devices as we know them today, the United States and other countries are not
prepared for disasters.
Box 1 highlights gaps between current POC devices and various problems with
technologies currently available. Without durable and robust POCT equipment,
diagnosis and treatment of victims at disaster sites becomes increasingly complicated
and hindered. To effectively and efficiently diagnose, monitor, and treat patients, the
current gaps in POCT technologies and devices must be closed. The POC Tech-
nologies Center (http://www.ucdmc.ucdavis.edu/pathology/poctcenter) is currently
conducting static and dynamic environmental stress tests to understand the environ-
mental limitations of POC devices and reagents in more detail.
Dynamic tests simulate realistic meteorologic conditions found in world regions with
high risk for newdemics. US Food and Drug Administration (FDA)-approved product
labelings typically state temperature limits, but current limits are inadequate for
most disaster conditions. Also, a POCT method that may be proven to work in envi-
ronmental extremes must also be validated for critically ill patient populations, which
few currently do.
Problems with preanalytical processing present an additional major challenge for
reliable POCT device performance. For example, in a recent study conducted by
Dighe and colleagues,41 unusually high false-positive potassium critical values led
the laboratory to investigate the preanalytical processing after concluding that the
Ta 4
PO nfluenza diagnostic tests
Ins ment/Manufacturer Performance Characteristics (%)
Im noassay Tests Type Target Time Sensitivity Specificity PPV NPV
3M apid Detection Flu A1B34,a http://
w.3M.com, St. Paul, MN
Chromatographic
immunoassay
Influenza A 15 min 70 100 99 93
Influenza B (nucleoprotein) 87 99 88 98
BD irectigen EZ Flu A1B,a,b http://www.
com, Franklin Lakes, NJ
Chromatographic
immunoassay
Influenza A 15 min 77–91 86–99 60–98 93–95
Influenza B 69–100 99–100 93–98 93–100
BD irectigen Flu A Kita,b http://www.bd.
, Franklin Lakes, NJ
Immunoassay Influenza A (nucleoprotein) 15 min 67–96 88–97 NA NA
BD rectigen FluA1 BKit35,b http://www.
com, Franklin Lakes, NJ
Immunoassay Influenza A 15 min 77–96 90–91 63–71 94–99
Influenza B (nucleoprotein) 71–88 98–100 82–100 98–100
Bi NOW Influenza A&B36,a,b,c http://
w.binax.com, Scarborough, ME
Chromatographic
immunoassay
Influenza A 15 min 77–83 96–99 88–97 95–96
Influenza B (nucleoprotein) 50–69 100 82–100 99
ES NE Influenza A&B,36 http://www.
rebio.co.jp, Tokyo, Japan
Chromatographic
immunoassay
Influenza A 15 min 67 100 100 89
Influenza B (nucleoprotein) 30 100 100 96
flu Rapid Influenza Test,d http://www.
iagnostics.com, Emeryville, CA
Lateral flow
immunoassay
Influenza A NA NA NA NA NA
Influenza B NA NA NA NA NA
Subtype A/H1 NA NA NA NA NA
Subtype A/H3 NA NA NA NA NA
In A&B Respi-Strip, http://www.
isbio.com, Gembloux, Belgium
Chromatographic
immunoassay
Influenza A 15 min 97 100 100 98
Influenza B (nucleoprotein) 97 100 100 98
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OSOM Influenza A & B Test,a,c http://
www.genzymediagnostics.com,
Framingham, MA
Chromatographic
immunoassay
Influenza A 10 min 74 96 90 90
Influenza B (nucleoprotein) 60 96 73 94
panfluID Rapid Influenza Test,d http://
www.hxdiagnostics.com, Emeryville,
CA
Lateral flow
immunoassay
Avian Influenza NA NA NA NA NA
QuickVue Influenza A1B Test,c http://
www.quidel.com, San Diego, CA
Lateral flow
immunoassay
Influenza A 10 min 77–94 89–99 62–91 95–99
Influenza B (nucleoprotein) 62–82 97–99 80–90 94–97
QuickVue Influenza Test,b,c http://www.
quidel.com, San Diego, CA
Lateral flow
immunoassay
Influenza A1B 10 min 73–81 96–99 92–96 85–93
No differentiation
(nucleoprotein)
Rockeby Influenza A Test,36,b http://www.
rockeby.com, Singapore
Immunoassay Influenza A (nucleoprotein) 10 min 10 100 100 74
SAS FluAlert, http://www.sascientific.
com, San Antonio, TX
Chromatographic
immunoassay
Influenza A 15 min 76 98 93 91
Influenza B (nucleoprotein) 15 min 91 99–100 100 99
Xpect Flu A&B Test Kit,37 http://www.
remelinc.com, Lenexa, KS
Chromatographic
immunoassay
Influenza A 15 min 90–100 100 100 97–100
Influenza B (nucleoprotein) 83–100 100 100 99–100
Nucleic AcidTests
Primer design, http://www.primerdesign.
co.uk, Southampton, UK
Real time qPCR H1N1 (swine flu) <2 h NA NA NA NA
proFLU plus,b http://www.prodesse.com,
Waukesha, WI
Real time RT-PCR Influenza A (matrix) 3 h 100 93 71 100
Influenza B (nonstructural NS1
& NS2)
98 99 80 100
(continued on next page)
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Instrument/Manufacturer Performance Characteristics (%)
Nucleic AcidTests Type Target Time Sensitivity Specificity PPV NPV
xTAG Respiratory viral panel,38,a Luminex,
http://www.luminexcorp.com, Austin, TX
Flow through
microsphere array
Influenza A <4 h 98 100 99 100
H1
H3
H5b
Influenza B 94 100 100 100
SARSb
Corona virus NL63b
Corona virus 229Eb
Corona virus OC43b
Corona virus HKU1b
RSV, subtype A
RSV, subtype B
Parainfluenza 1
Parainfluenza 2
Parainfluenza 3
Parainfluenza 4b
Metapneumovirus
Rhinovirus/
Enterovirus
Adenovirus
Data shown in the table are from product inserts unless otherwise noted.
Abbreviations: BD, Becton-Dickinson; NA, not available; NPV, negative predictive value; PPV, positive predictive value; qPCR, quantitative polymerase chain
reaction; RSV, respiratory syncytial virus; RT, reverse transcriptase; SARS, severe acute respiratory syndrome.
a FDA-approved.
b CE-approved.
c CLIA-waived.
d In development.
Table 4
(continued)
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Box1
Strategic planning for POCT in disaster settings: gap analysis
Discovery
Novel new POC technologies for complex POCT in different global settings
Operational characteristics
Native sample testing from complex matrices with minimal prenalytical processing
Cassette-contained sample processing to avoid (pathogen) contamination
Back-end biohazard disposal in the same cassette, which can be disposed of intact
Internal, automated, and electronic quality control; external proficiency testing
Battery operation with flexible multiple power supplies
Format, licensing, and standardization
Durable handheld and portable formats for different emergency settings
Simple, fast, smart, and easy use codified to achieve CLIA-waived status
Competency demonstrated beforehand as part of preparedness in disaster plan
Standardized test results verified with ‘‘new math’’ (eg, LS MAD curves)
Environmental robustness
Sensors on board to document location and environmental conditions
Durable reagents and equipment not susceptible to environmental stresses
Environmental certification based on dynamic stress testing
Suitability for meteorologic profiles of disaster sites worldwide
Diagnostic performance
Quantitative POC tests capable of satisfactory accuracy, sensitivity, and specificity
Multiplex or multiple patient testing with needs-based test clusters
Index case (eg, H1N1) and risk (eg, HIV 1/2 in emergency blood donors) identification
Broad-spectrum pathogen surveillance for hazards (eg, World Trade Center [WTC] cough)
Mutations and detection of multiresistant strains (eg, tuberculosis) in challenging
environments
Knowledge optimization
Full user awareness of performance characteristics based on field evaluations
Informatics compatibility, connectivity, and archival in small-world networks
Risk indexing of diagnostic targets, wireless results reporting, and outcomes monitoring
Cost-effectiveness for implementation in low-resource settings
Point-of-Care Testing for Disasters 601instrument was not the source of the errors. Laboratory personnel noted that when
false-positive potassium critical values were seen, a hemoglobin A1C test was also
ordered.
On investigation of the sample processing, Dighe and colleagues41 found that both
tubes were being packaged with ice and transported to the testing facility. Icing blood
tubes has been shown to lyse red blood cells and falsely elevate potassium levels.41
Laboratory technologists subsequently altered the transport requirement for hemo-
globin A1C and observed a substantial decrease in potassium false-positive values
in ensuing months.41 When POCT devices are reliable, these types of preanalytical
Kost et al602problems can be minimized or eliminated. To ensure best patient care, preanalytical
processing methods used on field-worthy POCT devices should be self-contained
and disposable, but free from confounding preanalytical errors.
Box 1 lists several other gaps that need to be addressed. For example, the introduc-
tion of locally smooth median absolute difference (LS MAD) curves as a mathematical
statistical method to visually analyze the accuracy of POCT blood glucose meters
shows that performance in hypoglycemic and hyperglycemic ranges of most blood
glucose meters in current use exceeds error tolerance limits for adult critically ill
patient populations.42,43 POCT technologies intended for emergency and disaster
settings and critically ill patient populations can be improved, standardized, and veri-
fied with this new math (see Box 1) to enable better performance and patient
outcomes.
The search and discovery of novel new POC technologies should be actively
pursued by researchers. Devices are needed in various global environments across
the world. In these different conditions, POCT will encounter new challenges to be
overcome. As noted above, POCT instruments must be environmentally robust and
capable of withstanding dynamic stresses (see Box 1). In addition, POCT devices
should be capable of diagnosing multiple pathogens with adequate clinical sensitivity
and specificity (see Box 1), ideally including extensively drug-resistant tuberculosis,
malaria, and influenza. New and novel POCT devices will be created in the future
featuring improved operational characteristics, environmental robustness, diagnostic
performance, and knowledge optimization that enable disaster responders to rapidly
diagnose and treat victims and fill current technology gaps.INTEGRATION STRATEGY: POCTAND SMALL-WORLD NETWORKS
Strategic placement of POCT devices within small-world networks (SWN) will
effectively facilitate rapid evidence-based medical decisions.5 SWNs enable informa-
tion to be transmitted quickly from site to site and facilitate quick triage of patients to
appropriate points of evaluation.5 SWNscan helpmanagePOCToperations to improve
overall efficiency and cost-effectiveness by integrating health care delivery compo-
nents, including home monitoring, primary care unit testing, mobile medical unit, alter-
nate medical care site, triage, emergency room, and local hospital resources.5
Thus, when a disaster situation arises, such as Hurricane Katrina, the tsunami in
Southeast Asia, or the novel H1N1 (swine flu) pandemic, SWNs can effectively allocate
POCT resources to allow for rapid and cost-effective patient care or isolation of index
cases, as needed, that is also efficient within the context of regional resources. This
strategic integration of POCT into regional aspects of disaster and emergency
response will ensure that patient care will be rapid and effective.SUMMARY
Use of POCT in disaster and emergency situations will efficiently facilitate rapid
evidence-based diagnosis at the site of patient care. A variety of tests are currently
available for POCT in hospitals, but the spectrum of POC tests for emergency and
disaster care must be broadened.
The development of pathogen test clusters, based on needs assessment survey
results, must be incorporated into new POCT device designs. Besides developing
innovative POCT devices, current gaps in POCT technology and availability must be
filled to ensure optimal patient care wherever the patient might be.
Point-of-Care Testing for Disasters 603Integration and global use of POCT in emergencies will help prevent newdemics
from accelerating as seen during Hurricane Katrina and the current influenza
pandemic (novel H1N1), while simultaneously improving immediate patient care.
When a disaster or emergency strikes and as POCT use becomes standard for SWN
preparedness, emergency medical responders, alternate medical facilities, and hospi-
tals will be ready to deal effectively with the crises and avoid the pitfalls of the past,
when adequate POCT was not available or not used efficiently.
However, given current state-of-the-art POCT, the United States and other coun-
tries are not prepared. Having environmentally robust and rapid POCT devices that
are deployable to disaster and emergency sites, and also validated for the care of
the critically ill, will bring care to the point of need where physicians and nurses can
make fast, evidence-based decisions for triage and treatment.
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